Your new experience awaits. Try the new design now and help us make it even better

BRIEF RESEARCH REPORT article

Front. Med.

Sec. Rheumatology

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1563796

This article is part of the Research TopicCardiovascular Comorbidities in Inflammatory Rheumatic DiseasesView all 11 articles

No difference in endothelial microvasculation measured by peripheral arterial tonometry (PAT) in patients with Sjögren's disease and matched controls

Provisionally accepted
Franziska  Maria TapkenFranziska Maria Tapken1Nadine  ZehrfeldNadine Zehrfeld1Malin  AbelmannMalin Abelmann1,2,3Anna Charlotte  Müller-VahlAnna Charlotte Müller-Vahl4Sabrina  BenzSabrina Benz4Tabea  SeeligerTabea Seeliger5Thomas  SkripuletzThomas Skripuletz5Torsten  WitteTorsten Witte4Kristina  SonnenscheinKristina Sonnenschein2Johann  BauersachsJohann Bauersachs2Udo  BavendiekUdo Bavendiek2Thomas  ThumThomas Thum3Anselm  A. DerdaAnselm A. Derda2,3*Diana  ErnstDiana Ernst4*
  • 1Department of Rheumatology & Immunology, Hannover Medical School, Hanover, Germany
  • 2Department of Angiology and Cardiology, Hannover Medical School, Hannover, Germany, Hannover, Germany
  • 3Institute for Molecular and Translational Therapy Strategies, Hannover Medical School, Hannover, Lower Saxony, Germany
  • 4Department of Rheumatology & Immunology, Hannover Medical School, Hannover, Germany, Hannover, Germany
  • 5Department of Neurology, Hannover Medical School, Hannover, Lower Saxony, Germany

The final, formatted version of the article will be published soon.

Sjögren's disease (SjD) is a connective tissue autoimmune disorder characterized by inflammatory infiltration of the exocrine glands, leading to symptoms such as dryness, pain and fatigue. Additionally, up to 50% of patients may experience extraglandular manifestations. SjD patients face a higher cardiovascular risk, including severe events like myocardial infarction and strokes, partly due to an increased likelihood of subclinical atherosclerosis. Therefore, identifying SjD patients at an early stage is essential to reduce morbidity and mortality.In this study, SjD patients who met the current ACR/EULAR 2016 classification criteria were consecutively enrolled in our outpatient clinic. A control cohort was recruited through a multimedia call for participation. To assess changes in endothelial functions, a reactive hyperemia index (RHI) was calculated using peripheral arterial tonometry with the EndoPAT® measurement device. RHI values below 1.67 were considered pathological.The dataset consists of 49 SjD patients and 27 healthy controls. Both groups had similar ages and comparable cardiovascular risk factors. No differences in RHI were observed between the two cohorts. The only significant factor that was predictive for a low RHI was an increased Body Mass Index (p=0.036). These findings suggest that EndoPAT measurements may not be a suitable method for detecting changes in endothelial function specific to patients with SjD. FTa received a scholarship by Gesellschaft der Freunde der Medizinischen Hochschule Hannover e.V., KlinStrucMed programm 2023/2024.

Keywords: Endothelial dysfunction, Sjögren´s disease, cardiovascular risk, EndoPat, Peripheral arterial tonometry, miRNA, Sjögren disease, Endothel dysfunction, cardiovasccular risk factors

Received: 20 Jan 2025; Accepted: 06 Jun 2025.

Copyright: © 2025 Tapken, Zehrfeld, Abelmann, Müller-Vahl, Benz, Seeliger, Skripuletz, Witte, Sonnenschein, Bauersachs, Bavendiek, Thum, Derda and Ernst. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Anselm A. Derda, Department of Angiology and Cardiology, Hannover Medical School, Hannover, Germany, Hannover, Germany
Diana Ernst, Department of Rheumatology & Immunology, Hannover Medical School, Hannover, Germany, Hannover, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.